Eva Kocsmar
Overview
Explore the profile of Eva Kocsmar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jakab A, Zarandy L, Kocsmar I, Varkonyi T, Kenessey I, Szijarto A, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335115
Both esophageal squamous cell carcinoma (ESQCC) and adenocarcinoma (EAC) are known to have poor prognosis. We aimed to investigate the invasion front areas of 57 ESQCC and 43 EAC cases...
2.
Kocsmar E, Kocsmar I, Elamin F, Papai L, Jakab A, Varkonyi T, et al.
Geroscience
. 2024 May;
46(6):6101-6114.
PMID: 38691298
COVID-19, caused by SARS-CoV-2, manifests with differing severity across distinct patient subgroups, with outcomes influenced by underlying comorbidities such as cancer, which may cause functional and compositional alterations of the...
3.
Kocsmar E, Schmid M, Cosenza-Contreras M, Kocsmar I, Foll M, Krey L, et al.
Cell Mol Life Sci
. 2023 Apr;
80(5):117.
PMID: 37020120
Protein expression is a primary area of interest for routine histological diagnostics and tissue-based research projects, but the limitations of its post-mortem applicability remain largely unclear. On the other hand,...
4.
Szalai L, Jakab A, Kocsmar I, Szirtes I, Kenessey I, Szijarto A, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230653
The prognostic value of histological phenomena tumor budding (TB) and poorly differentiated clusters (PDCs) have been less studied in gastric cancer (GAC) and the data provided so far are controversial....
5.
Kocsmar I, Kocsmar E, Pajor G, Kulka J, Szekely E, Kristiansen G, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230493
Progression of non-muscle-invasive bladder cancer (NMIBC) to muscle-invasive disease (MIBC) significantly worsens life expectancy. Its risk can be assessed by clinicopathological factors according to international guidelines. However, additional molecular markers...
6.
Tolkach Y, Kremer A, Lotz G, Schmid M, Mayr T, Forster S, et al.
Cancers (Basel)
. 2022 Sep;
14(18).
PMID: 36139600
Background: Canonical androgen receptor (AR) signaling regulates a network of DNA repair genes in prostate cancer (PCA). Experimental and clinical evidence indicates that androgen deprivation not only suppresses DNA repair...
7.
Kocsmar E, Lotz G
Diagnostics (Basel)
. 2022 Jun;
12(6).
PMID: 35741234
In their article, Skebrinska and colleagues analysed the potential pitfalls of detecting () by serology, histological (Giemsa) and immunohistochemical (IHC) staining. However, in the Introduction, the authors state: "…IHC is...
8.
Kim J, Kocsmar I, Buzas G, Szirtes I, Rusz O, Diczhazi C, et al.
Pathol Oncol Res
. 2021 Jul;
27:1609863.
PMID: 34267605
The global rise in clarithromycin (Cla) resistance is considered to be the main contributor of () eradication failures. In nearly half of the Cla-resistant infections, Cla-susceptible bacteria are simultaneously present...
9.
Kocsmar E, Buzas G, Szirtes I, Kocsmar I, Kramer Z, Szijarto A, et al.
Nat Commun
. 2021 Apr;
12(1):2255.
PMID: 33859206
Clarithromycin is a macrolide antibiotic widely used for eradication of Helicobacter pylori infection, and thus resistance to this antibiotic is a major cause of treatment failure. Here, we present the...
10.
Kocsmar E, Kocsmar I, Szalai L, Lendvai G, Szijarto A, Schaff Z, et al.
Sci Rep
. 2020 Dec;
10(1):22212.
PMID: 33335133
Small subtype of the gastrointestinal stromal tumor (micro-GIST, MG) is usually asymptomatic and is frequently found incidentally in association with gastric adenocarcinoma (GAC). The background of this coincidence is still...